The preceding analysis demonstrated a decline in CD8+ Trm-dys and CD8+ Tbys-cyt, accompanied by an increase in CD4+ Tcon, within the TIME of NSCLC patients following NCIT. This evidence concerns the gene CD4 and non-small cell lung carcinoma.